Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros




Base de datos
Intervalo de año de publicación
1.
Theranostics ; 10(4): 1572-1589, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32042323

RESUMEN

Reconstruction of osteoporotic bone defects is a clinical problem that continues to inspire the design of new materials. Methods: In this work, bioceramics composed of strontium (Sr)-doped hydroxyapatite (HA) whiskers or pure HA whiskers were successfully fabricated by hydrothermal treatment and respectively named SrWCP and WCP. Both bioceramics had similar three-dimensional (3D) porous structures and mechanical strengths, but the SrWCP bioceramic was capable of releasing Sr under physiological conditions. In an osteoporotic rat metaphyseal femoral bone defect model, both bioceramic scaffolds were implanted, and another group that received WCP plus strontium ranelate drug administration (Sr-Ran+WCP) was studied for comparison. Results: At week 1 post-implantation, osteogenesis coupled blood vessels were found to be more common in the SrWCP and Sr-Ran+WCP groups, with substantial vascular-like structures. After 12 weeks of implantation, comparable to the Sr-Ran+WCP group, the SrWCP group showed induction of more new bone formation within the defect as well as at the implant-bone gap region than that of the WCP group. Both the SrWCP and Sr-Ran+WCP groups yielded a beneficial effect on the surrounding trabecular bone microstructure to resist osteoporosis-induced progressive bone loss. While an abnormally high blood Sr ion concentration was found in the Sr-Ran+WCP group, SrWCP showed little adverse effect. Conclusion: Our results collectively suggest that the SrWCP bioceramic can be a safe bone substitute for the treatment of osteoporotic bone defects, as it promotes local bone regeneration and implant osseointegration to a level that strontium ranelate can achieve.


Asunto(s)
Regeneración Ósea/efectos de los fármacos , Fémur/patología , Hidroxiapatitas/farmacología , Osteoporosis/tratamiento farmacológico , Estroncio/farmacología , Animales , Materiales Biocompatibles/química , Sustitutos de Huesos/efectos adversos , Sustitutos de Huesos/química , Femenino , Fémur/efectos de los fármacos , Hidroxiapatitas/administración & dosificación , Hidroxiapatitas/química , Ensayo de Materiales/estadística & datos numéricos , Oseointegración/efectos de los fármacos , Osteogénesis/efectos de los fármacos , Impresión Tridimensional , Ratas , Ratas Sprague-Dawley , Estroncio/administración & dosificación , Estroncio/química , Andamios del Tejido/química , Vibrisas/química
2.
Materials (Basel) ; 13(2)2020 Jan 08.
Artículo en Inglés | MEDLINE | ID: mdl-31936228

RESUMEN

This article presents a facile synthesis method used to obtain new composite films based on polylactic acid and micro-structured hydroxyapatite particles. The composite films were synthesized starting from a polymeric solution in chloroform (12 wt.%) in which various concentrations of hydroxyapatite (1, 2, and 4 wt.% related to polymer) were homogenously dispersed using ultrasonication followed by solvent evaporation. The synthesized composite films were morphologically (through SEM and atomic force microscopy (AFM)) and structurally (through FT-IR and Raman spectroscopy) characterized. The thermal behavior of the composite films was also determined. The SEM and AFM analyses showed the presence of micro-structured hydroxyapatite particles in the film's structure, as well as changes in the surface morphology. There was a significant decrease in the crystallinity of the composite films compared to the pure polymer, this being explained by a decrease in the arrangement of the polymer chains and a concurrent increase in the degree of their clutter. The presence of hydroxyapatite crystals did not have a significant influence on the degradation temperature of the composite film.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA